DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of…
Regulator gives nod to emergency use of DRDO’s Anti-Covid drug, that will come in powder form
The Drugs Controller General of India (DCGI) on Saturday approved the emergency use of an anti-Covid oral drug…